QLT PhotoTherapeutics (QLTI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (393)	1/10/1999 7:32:00 PM
From: Zeev Hed	Read Replies (1) of 1321

Ian, actually, in the health care field, it is typically safe to assume "the rest of the world" at the same number (that is the factor I have been using in a large number of "business plans" for medical instrumentation system for years) as the total in the US (I should say expected use not "head count of potential patients) and this is indeed related to less intensive medicine in the rest of the world. For AMD that might be somewhat different and thus Julia's 2.5 number could be rational, and possibly a little optimistic. Zeev

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next